Key Highlights

• Amazon UK trailing twelve-month sales reached approximately $2.27 million, a 90% increase from approximately $1.19 million in the prior twelve-month period.

• Net profit from the Amazon UK channel was approximately $525,000, representing a net Margin of approximately 23% after all direct costs.

• Advertising costs accounted for only 2.4% of trailing twelve-month sales, while refunds remained below 1% of sales.

• The company expects Amazon UK sales to grow approximately 72% over the next twelve months, reaching approximately $3.9 million.

Cosmos Health Inc.(NASDAQ:COSM), a diversified, vertically integrated global healthcare group, provided an update on November 4, 2026, regarding the performance of its Amazon UK business. The company reported that trailing twelve-month sales from November 1, 2025, to November 2, 2026, reached approximately $2.27 million, a 90% increase compared with approximately $1.19 million in the prior twelve-month period.

Sales Trajectory and Volume

During the trailing twelve-month period, Cosmos Health sold 116,978 units to customers in the United Kingdom through the Amazon platform, averaging approximately 320 units per day. The growth trajectory built steadily throughout the year, with monthly sales increasing from approximately $144,000 in November 2025 to more than $215,000 in each of the four months from July through October 2026. The company noted that these four months were its highest-performing months on Amazon UK to date.

The sales are driven by the company's portfolio of proprietary pharmaceutical and nutraceutical brands, which include Sky Premium Life, Mediterranation, bio-bebe, C-Sept, and C-Scrub. The company manufactures these products through its Subsidiary Cana Laboratories, which is licensed under European Good Manufacturing Practices and certified by the European Medicines Agency.

Profitability and Cost Efficiency

The company highlighted the cost efficiency of its Amazon UK channel operations. Advertising costs represented only 2.4% of trailing twelve-month sales, while product refunds remained below 1% of total sales. After accounting for all direct channel costs, including Amazon fees, cost of goods, shipping, advertising, and VAT, the Amazon UK Business generated net profit of approximately $525,000 on Revenue of approximately $2.27 million, equating to a net margin of approximately 23%.

Cosmos Health described these results as reflective of what it considers healthy underlying Demand for its proprietary products and an efficient, scalable sales channel. The company positioned the Amazon UK performance as part of its broader transition toward a higher-margin business model, in which proprietary brands sold through direct online channels can achieve meaningfully higher profitability than traditional distribution activities.

Growth Outlook and Strategy

Looking ahead, Cosmos Health expects Amazon UK sales to grow approximately 72% over the next twelve months compared with the trailing twelve-month period, reaching approximately $3.9 million, or an average of approximately $325,000 per month. This outlook is based on the company's current sales trends and planned growth initiatives on the platform.

The Amazon UK channel is part of Cosmos Health's broader UK operations, which also include pharmaceutical and parapharmaceutical distribution through its Harlow-based facilities. The company has been expanding its geographic reach throughout Europe, Asia, and North America, with offices and distribution centers in Greece and the UK.

What the Numbers Indicate

The Amazon UK results illustrate the margin differential between Cosmos Health's proprietary Brand sales and its distribution activities. A 23% net profit margin on a direct-to-consumer E-commerce channel contrasts favorably with the typically lower margins associated with wholesale pharmaceutical distribution. With advertising costs at 2.4% of sales and refund rates below 1%, the channel appears to be operating with relatively low customer Acquisition and return costs. The projected 72% sales growth for the next twelve months, if achieved, would bring the Amazon UK business closer to $4 million in annual revenue, though it would still represent a modest portion of the company's overall revenue mix.